Business Context and Reporting Period
Company: Core Scientific, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: December 2, 2024 (Event Date: December 5, 2024)
Context: The Company completed a private offering of convertible senior notes to raise capital for general corporate purposes.
Key Financial Metrics
- Debt Issuance: $625.0 million aggregate principal amount of 0.00% Convertible Senior Notes due 2031.
- Offering Structure: Included the full exercise of an option to purchase an additional $75.0 million in Notes.
- Net Proceeds: Estimated at approximately $608.7 million after discounts, commissions, and expenses.
- Interest Rate: 0.00% (No regular interest; principal does not accrete).
- Maturity Date: June 15, 2031.
- Conversion Price: Approximately $22.49 per share (Initial conversion rate: 44.4587 shares per $1,000 principal).
- Maximum Dilution: Up to 39,596,000 shares of Common Stock issuable upon conversion (based on initial maximum conversion rate).
Material Changes Versus Prior Period
This filing represents a significant change in the Company's capital structure through the creation of a new direct financial obligation. The Company has increased its debt load by $625.0 million in principal, replacing or supplementing prior liquidity sources with long-term convertible debt. The filing does not provide comparative financial metrics (revenue, profit, cash flow) for the current period versus prior periods as it is a transaction-specific report.
Guidance, Outlook, and Material Terms
- Use of Proceeds: General corporate purposes, including working capital, operating expenses, capital expenditures, acquisitions, or repurchases of securities.
- Conversion Rights: Noteholders may convert notes under specific conditions, including if the stock price exceeds 130% of the conversion price for 20 of 30 trading days (after Q1 2025), or upon certain corporate events. Conversions may be settled in cash, stock, or a combination at the Company's election.
- Redemption: The Company may redeem notes on or after June 22, 2028, subject to liquidity conditions and stock price thresholds (130% of conversion price).
- Repurchase Rights: Noteholders may require repurchase upon a "Fundamental Change" or on December 15, 2027, at principal plus accrued interest.
- Events of Default: Includes payment defaults, failure to convert, bankruptcy, and defaults on other indebtedness exceeding $25 million.
Investor Verification Checklist
- Verify the final net proceeds received versus the estimated $608.7 million.
- Monitor the Company's stock price relative to the $22.49 conversion price to assess conversion risk and potential dilution.
- Review the Indenture (Exhibit 4.1) for specific definitions of "Fundamental Change" and "Make-Whole Fundamental Change."
- Assess the Company's liquidity position post-offering to ensure compliance with redemption conditions and covenant requirements.
- Confirm the impact of the 39,596,000 potential new shares on existing shareholder equity.